MedPath

Metabolic Changes Induced by Genetically Modified Potatoes

Not Applicable
Conditions
Endocrine Metabolism
Glucose Metabolism
Satiety
Registration Number
NCT00953966
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

Starches from genetically modified potatoes, which differed in terms of amylose, amylopectin and phosphate content, were tested in a human randomized controlled trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
50
Inclusion Criteria
  • healthy males
Exclusion Criteria
  • no acute oder severe chronic diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Glucose metabolism2 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Charité, Dept. of Endocrinology, Diabetes and Nutrition

🇩🇪

Berlin, Germany

Charité, Dept. of Endocrinology, Diabetes and Nutrition
🇩🇪Berlin, Germany
Joachim Spranger, MD
Contact
0049308445
joachim.spranger@charite.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.